Guest Column: 4 Tips For Speeding Device Reviews, Even Without An 'Expedited' Pathway
This article was originally published in The Gray Sheet
Executive Summary
FDA's new Expedited Access Program offers an accelerated pathway for select devices and diagnostics, but companies can help speed the regulatory process even for products that don't qualify for the program by following certain strategies, explains David Novotny, with Novella Clinical.